TY - JOUR
T1 - Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
AU - Sud, Amit
AU - Thomsen, Hauke
AU - Law, Philip J
AU - Försti, Asta
AU - Filho, Miguel Inacio da Silva
AU - Holroyd, Amy
AU - Broderick, Peter
AU - Orlando, Giulia
AU - Lenive, Oleg
AU - Wright, Lauren
AU - Cooke, Rosie
AU - Easton, Douglas
AU - Pharoah, Paul
AU - Dunning, Alison
AU - Peto, Julian
AU - Canzian, Federico
AU - Eeles, Rosalind
AU - Kote-Jarai, ZSofia
AU - Muir, Kenneth
AU - Pashayan, Nora
AU - Hoffmann, Per
AU - Nöthen, Markus M
AU - Jöckel, Karl-Heinz
AU - von Strandmann, Elke Pogge
AU - Lightfoot, Tracy
AU - Kane, Eleanor
AU - Roman, Eve
AU - Lake, Annette
AU - Montgomery, Dorothy
AU - Jarrett, Ruth F.
AU - Swerdlow, Anthony J.
AU - Engert, Andreas
AU - Orr, Nick
AU - Hemminki, Kari
AU - Houlston, Richard S.
AU - PRACTICAL consortium
N1 - © The Author(s) 2017
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Several susceptibility loci for classical Hodgkin lymphoma have been reported. However, much of the heritable risk is unknown. Here, we perform a meta-analysis of two existing genome-wide association studies, a new genome-wide association study, and replication totalling 5,314 cases and 16,749 controls. We identify risk loci for all classical Hodgkin lymphoma at 6q22.33 (rs9482849, P = 1.52 × 10-8) and for nodular sclerosis Hodgkin lymphoma at 3q28 (rs4459895, P = 9.43 × 10-17), 6q23.3 (rs6928977, P = 4.62 × 10-11), 10p14 (rs3781093, P = 9.49 × 10-13), 13q34 (rs112998813, P = 4.58 × 10-8) and 16p13.13 (rs34972832, P = 2.12 × 10-8). Additionally, independent loci within the HLA region are observed for nodular sclerosis Hodgkin lymphoma (rs9269081, HLA-DPB1*03:01, Val86 in HLA-DRB1) and mixed cellularity Hodgkin lymphoma (rs1633096, rs13196329, Val86 in HLA-DRB1). The new and established risk loci localise to areas of active chromatin and show an over-representation of transcription factor binding for determinants of B-cell development and immune response.
AB - Several susceptibility loci for classical Hodgkin lymphoma have been reported. However, much of the heritable risk is unknown. Here, we perform a meta-analysis of two existing genome-wide association studies, a new genome-wide association study, and replication totalling 5,314 cases and 16,749 controls. We identify risk loci for all classical Hodgkin lymphoma at 6q22.33 (rs9482849, P = 1.52 × 10-8) and for nodular sclerosis Hodgkin lymphoma at 3q28 (rs4459895, P = 9.43 × 10-17), 6q23.3 (rs6928977, P = 4.62 × 10-11), 10p14 (rs3781093, P = 9.49 × 10-13), 13q34 (rs112998813, P = 4.58 × 10-8) and 16p13.13 (rs34972832, P = 2.12 × 10-8). Additionally, independent loci within the HLA region are observed for nodular sclerosis Hodgkin lymphoma (rs9269081, HLA-DPB1*03:01, Val86 in HLA-DRB1) and mixed cellularity Hodgkin lymphoma (rs1633096, rs13196329, Val86 in HLA-DRB1). The new and established risk loci localise to areas of active chromatin and show an over-representation of transcription factor binding for determinants of B-cell development and immune response.
KW - Journal Article
U2 - 10.1038/s41467-017-00320-1
DO - 10.1038/s41467-017-00320-1
M3 - Article
C2 - 29196614
SN - 2041-1723
VL - 8
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1892 (2017)
ER -